Effect of remifentanil on three effect-site concentrations of propofol and their relationship during electroencephalography at loss of response, at maximum alpha power, and at onset of burst suppression: a prospective randomized trial

J Anesth. 2024 Jun;38(3):371-376. doi: 10.1007/s00540-024-03318-4. Epub 2024 Feb 20.

Abstract

Purpose: The effect-site concentration (Ce) at loss of response (Ce-LOR) to propofol closely correlates both with Ce as electroencephalographic alpha power becomes highest (Ce-alpha) and with Ce at onset of burst suppression (BS) (Ce-OBS), when no opioids are administered. Co-administration of opioids dose-dependently decreases Ce-LOR. We investigated the influence of remifentanil on the relationship between these three Ces.

Methods: After receiving approval from our local ethical committee, with written informed consent, we enrolled 90 participants (ASA-PS I or II) who were scheduled for elective surgery. Participants were randomly assigned to three groups: constant remifentanil Ce 0 ng/ml (Remi_0); 1 ng/mL (Remi_1); and 2 ng/mL (Remi_2). We recorded both raw EEG and EEG-derived parameters on a computer. After reaching remifentanil equilibrium, we administered propofol using a target-controlled infusion pump such that propofol Ce increased to about 0.3 μg/mL/min. After determining Ce-LOR, we administered 0.6 mg/kg of rocuronium and started mask ventilation. The study protocol ended after observation of BS.

Results: Three participants were excluded. Ce-LOR in each group (Remi_0, Remi_1, Remi_2) was 2.00 ± 0.58 μg/mL, 1.43 ± 0.49 μg/mL, and 1.37 ± 0.42 μg/mL. Ce-alpha was 2.91 ± 0.63 μg/mL, 2.30 ± 0.41 μg/mL, and 2.12 ± 0.39 μg/mL. Ce-OBS was 3.80 ± 0.69 μg/mL, 3.25 ± 0.68 μg/mL, and 2.90 ± 0.57 μg/mL. In three other instances, Ce was decreased by remifentanil. Generalized linear model analysis revealed that remifentanil had no influence on the relationship between the three Ces.

Conclusion: During propofol anesthesia, even low concentrations of remifentanil shifted concentration-related electroencephalographic changes.

Keywords: Interindividual variation; Opioid; Pharmacodynamics; Propofol.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / pharmacology
  • Anesthetics, Intravenous* / administration & dosage
  • Anesthetics, Intravenous* / pharmacology
  • Dose-Response Relationship, Drug
  • Electroencephalography* / drug effects
  • Electroencephalography* / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piperidines / administration & dosage
  • Piperidines / pharmacology
  • Propofol* / administration & dosage
  • Propofol* / pharmacology
  • Prospective Studies
  • Remifentanil* / administration & dosage
  • Remifentanil* / pharmacology